McKesson in record $150 million U.S. settlement over suspicious drug orders

(Reuters) - McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers.